Intrathecal drug therapy using the Codman Model 3000 constant flow implantable infusion pumps: Experience with 17 cases

Spinal Cord

Volumn 43, Issue 4, 2005, Pages 214-218

  Ethans, K D ^a,c   Schryvers, O I ^a   Nance, P W ^b   Casey, A R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Infusion pumps; Muscle spasticity; Subarachnoid space

Indexed keywords

BACLOFEN;

ACCURACY; ADULT; CEREBRAL PALSY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG INFUSION; DRUG OVERDOSE; DRUG SAFETY; EVALUATION; FEMALE; HUMAN; INFUSION PUMP; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELIABILITY; REVIEW; SEROMA; SKIN ULCER; SPINAL CORD INJURY; SUBARACHNOID SPACE; VALVE; WOUND DEHISCENCE;

ADOLESCENT; ADULT; BACLOFEN; CHILD; EVALUATION STUDIES; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 17444413099     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101684     Document Type: Review

References (26)

1. Nance PW, Schryvers OI, Schmidt BJ, Dubo HI, Fewer D. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995; 22: 22-29.
2. Coombs DW, Pageau MG, Saunders RL, Mroz WT. Intraspinal narcotic tolerance: preliminary experience with continuous bupivicane HCL infusion via implanted infusion device. Int J Artif Organs 1982; 5: 379-382.
3. Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity, J Neurosurg 1987; 66: 181-185.
4. Nance P, Meythaler J, Intrathecal drug therapy. Phys Med Rehab Clin N Am 1999; 10: 385-401.
5. Zierski J, Muller H, Dralle D, Wurdinger T. Implanted pump systems for treatment of spasticity, Acta Neurochir Suppl (Wien) 1988; 43: 94-99.
6. Becker WJ, Harris CJ, Long ML, Ablett DP, Klein GM, DeForge DA. Long term intrathecal baclofen therapy in patients with intractable spasticity. Can J Neurol Sci 1995; 22: 208-217.
7. Gardner B et al. Intrathecal baclofen - a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems. Paraplegia 1995; 33: 551-554.
8. Codman & Shurtleff, Inc. Products: implantable pumps: pump overview. http://www.codmanpain.com/Products_pumps_overview.asp. 2004.
9. Szakacs JG, Szakacs JE, Karl RC. Surgical resection versus perfusion in the treatment of metastatic and primary tumors. Ann Clin Lab Sci 1990; 20: 245-247.
10. Coombs DW, Fine N, Spinal anesthesia using subcutaneously implanted pumps for intrathecal drug infusion. Anesth Analg 1991; 73: 226-231.
11. Kemeny MM. The surgical aspects of the totally implantable hepatic artery infusion pump. Arch Surg 2001; 136: 348-352.
12. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85: 458-467.
13. Coffey RJ et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226-232.
14. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 2001; 82: 155-161.
15. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996; 77: 35-39.
16. Campbell WM et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 2002; 44: 660-665.
17. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN, Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001; 32: 2099-2109.
18. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 1992; 71: 321-327.
19. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992; 77: 236-240.
20. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 2000; 79: 536-541.
21. Dario A, Scamoni C, Bono G, Ghezzi A, Zaffaroni M. Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion. Funct Neurol 2001; 16: 311-315.
22. Saltuari L et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli) 1992; 14: 187-194.
23. Levin AB, Sperling KB. Complications associated with infusion pumps implanted for spasticity. Stereotact Funct Neurosurg 1995; 65: 147-151.
24. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997; 87: 409-414.
25. Pasquier Y, Cahana A, Schnider A. Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord 2003; 41: 700-702.
26. Codman & Shurtleff Inc. Codman 3000 Series Constant Flow Implantable Pump with Bolus Safety Valve: Instructions for use, TLB2862M Raynham, MA, USA, pp 25-26.